CUE
Cue Biopharma, Inc. · Healthcare
Chief Executive Officer Shao-Lee Lin sold $1.6M of Cue Biopharma, Inc.
Sold$1,606,562
$27.58Price
58,258Shares
−8%Stake
What CUE did after the filing
- The stock from Tue, Aug 18 open, $27.39
- −5.5%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Sep 30 close.
Traded Wed, Aug 12. Filed Fri, Aug 14, 8:46 PM ET, after the close. Returns use the Aug 18 open and the Sep 30 close. Not investment advice.